Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FUSN just taken over.

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Mar 19, 2024 12:13pm

128 Views

Post# 35940768

RE:RE:FUSN just taken over.

I'd settle for a fair bet less than $6/share (probably even half that if it's sooner rather than later) IF it's a MRK stock trade (an dnot a cash buyout.)

Who has Merck stepped up to the plate for recently? Anyone?
Their stock is trading well enough maybe they ought to use a little of it for an acquisition...
(One billion worth of MRK stock would add less than 1% to their total outstanding shares!)

<< Previous

Bullboard Posts

Next >>

Tilray Brands launches health-conscious cannabis drinks